At Adalid, we develop next-generation lipid nanoparticles for gene delivery. We strongly believe that the next-generation of LNPs depends not only on the design of ionizable lipids that drive delivery efficacy, but also on a fully tunable overall composition tailored to meet the specific requirements of each therapeutic application. Our technology encompasses the design and synthesis of ionizable lipids with tunable properties, customizable compositions tailored to specific needs (e.g., multi-cargo delivery, prolonged blood circulation), and advanced outer shell architectures that enable flexible attachment of targeting moieties, omitting PEG-lipid.
| Website | https://www.adalidsciences.com |
| Employees | 15 (9 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Pharmaceutical Solutions, Pharmaceutical Development, Lipid Nanoparticles, Drug Delivery Systems, Pharmaceutical Technology, Novel Drug Delivery, Bioavailability Enhancement, Pharmaceutical Research, Drug Product Development, Innovative Drug Delivery, Advanced Drug Delivery, Rna Delivery, Drug Stability, Gene Therapy |
| Competitors | Research Pharmaceutical Services, PPD, Medpace, WuXi AppTec, Simulations Plus, Inc., ICON plc, Charles River Laboratories, BioPharma Services Inc., Certara, biostat.com +39 more (view full list) |
Looking for a particular Adalid Sciences employee's phone or email?
Adalid Sciences Questions
Klara Saskova is the Co-Founder and Chief Executive Officer of Adalid Sciences.
9 people are employed at Adalid Sciences.
Top Adalid Sciences Employees
-
41
-
1
-
2
-
Martin Hadzima
R and D Scientist at Adalid Sciences
Prague, Czechia -
1
